No price history available for this symbol yet.
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Sector
Drug Manufacturers - Specialty & Generic
LIWANLI Innovation Co., Ltd. operates within the biomedical science sector, concentrating on the development and distribution of nutrition and healthcare solutions. The company's diverse product portfolio, which notably features the Vigoway line and various powdered formulations, is designed to serve a wide range of consumers, including men, women, seniors, and children. Its extensive offerings encompass products such as probiotic enzymes, active nutrients, resveratrol red grape extract, and a variety of soft gels (including those with algae DHA, shea butter with type II collagen, and algae astaxanthin Q10). Other specialized items include cordyceps militaris powder, tooth guard tablets, bovine and goat's milk bites, bilberry tablets, and DHA and vitamin D3 drops, among others. The firm was formerly known as Carry Technology International Co., Ltd. before officially adopting its current name, LIWANLI Innovation Co., Ltd., in 2015. Established in 1980, the company's headquarters are located in New Taipei City, Taiwan.
www.liwanli.com.twNo one on the platform currently holds 3054.TW.
No tracked institution reports a position in 3054.TW as of their last filing.
No one on the platform has traded 3054.TW yet.
Consensus-seeded revenue, margins, and exit multiples. This is a scenario tool, not investment advice.
Analyst estimates unavailable for this ticker.
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
| Symbol | Price | Today | Mkt cap | P/E |
|---|---|---|---|---|
| 3054.TWLIWANLI Innovation Co., Ltd. | $55.60 | +1.65% | $4.5B | — |
| 1780.TWOAllied Biotech Corporation | $24.50 | -1.21% | $2.7B | — |
| 1796.TWOGeneFerm Biotechnology Co., Ltd. | $29.20 | +0.00% | $1.2B | — |
| 4116.TWOBenQ Medical Technology Corporation | $39.45 | -0.38% | $1.8B | — |
| 4132.TWOGolden Biotechnology Corporation | $3.47 | +0.00% | $632M | — |
| 4153.TWODIVA Laboratories, Ltd. | $31.80 | +0.00% | $1.9B | — |
| 4172.TWOInnoPharmax Inc. | $10.60 | -0.47% | $1.2B | — |
Source: Financial Modeling Prep · peers by sector/industry